On behalf of Prof. Ulrich Jäger, member of the BioMed Alliance Board of Directors and of the Monitoring Horizon 2020 Task Force, we are asking you to provide your input to improve Horizon 2020 and the next Research and Innovation… Continue Reading

The 2015 has been a very important year for the EAN, mainly signed by the celebration of the first EAN Congress in Berlin last June. Many other important achievements have been reached by the EAN during this year, thank to the hard and generous work of the EAN President, Executive Board, Committees, Panels, and so many other EAN members. This end of the year gives us the special opportunity to thank all who have contributed to the EAN successful development, and to invite everybody to look forward to even more and better to come.

is available now! Click here to read. The European Journal of Neurology is free of charge for EAN members! Log-in on www.eaneurology.org. If you encounter difficulties accessing the Journal, please contact headoffice@eaneurology.org. European Journal of Neurology – January 2016 issue… Continue Reading

See the latest Reviews Radiological imaging in acute ischaemic stroke Neuromyelitis optica: a positive appraisal of seronegative cases See  more on http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1468-1331/homepage/reviews.htm Did you see the Special Issue? ParadigMS Don’t miss the Invited Reviews Virtual Issue See the latest Special… Continue Reading

The European Academy of Neurology was founded just 18 months ago and is becoming increasingly accepted as a hub for scientific knowledge and premier education (please see the EAN movie). This is reflected in the number of neurologists and trainees who join the EAN as members. To remind you: EAN has close to 25 000 associated members from 47 national European Member Societies, but accepts neurologists wanting to upgrade their membership as individual members.

David Vodušek (DV): The International Association for the Study of Pain (IASP) declared at the last World Congress on Pain in Buenos Aires that the period, October 2014 to December 2015, would be the Global Year Against Neuropathic Pain. What do you consider the most important achievement of this action? Chris Wells (CW): The Global Year Against Pain evolved from an idea of David Niv’s, former European Pain Federation (EFIC) President and IASP Council member. He conceived the idea of a Day Against Pain in 2001 and this developed into first a Week and then a Year Against Pain, which IASP and EFIC now jointly sponsor and promote.

Elena Moro (EM): As Programme Committee Chair, can you share you vision about the role of the EAN within the community of European Neurologists? Paul Boon (PB): I believe EAN has a unique mission to provide a platform for neurology in Europe, at a large scale and high level of professionality. Europe has a strong tradition of clinical discoveries, scientific breakthroughs and academic teaching in the field of neurology.

The eBbrain e-learning programme is a gold standard in interactive online learning tool for professionals in neuroscience. One of the most challenging fields of neurology is that of neuroinflammatory disorders, conditions were pathological immune responses damage components of the nervous… Continue Reading

Prof. G. Deuschl, President of the EAN and Prof. K. Lees President of ESO are pleased to announce that EAN has joined with ESO to promote optimal management of stroke in Europe. EAN and ESO are the leading societies for neurologists and stroke specialists, respectively, in Europe.

Electromyography (EMG) is the use of electrical signals from voluntary muscle to diagnose weakness as being due to nerve or muscle disease or disorders of the central nervous system. At EMG the potentials are recorded from muscle at rest, during weak effort and during maximal voluntary effort.

For December 2015 we have selected: Ramanujam R, Hedstrom A-K, Manouchehrinia A, et al. Effect of smoking cessation on multiple sclerosis prognosis. JAMA Neurol 2015; 72(10):1117-1123. The usual course of multiple sclerosis (MS) is characterized by the conversion to secondary progressive disease within about 20 years from the first attack. Great efforts are currently made to modify the disease progression with the use of aggressive and expensive medical treatments.

by Delia Lenzi Researchers working with gene-editing techniques (CRISPR) have managed to ensure that an engineered mosquito would pass on its new Plasmodium falciparum resistance genes to nearly all of its offspring— and note, not just half, as would normally… Continue Reading

It is a great pleasure to introduce the recipients of the Research Fellowship 2016 (in alphabetical order):

by Martin Rakusa and Ulf Kallweit Sleep disorders are an area, where doctors of different specialities meet. However, they are also that part of neurology, which is often overlooked. To strengthen connection between young neurologists and sleep specialists, Young European… Continue Reading

by Erich Schmutzhard and Eveline Sipido The 7th RTC took place in Khartoum, Sudan from 15 to 17 October 2015 and was hosted by the University of Khartoum. The RTC, organised by the EAN – European Academy of Neurology, was… Continue Reading